N
Nicola Gebbia
Researcher at University of Palermo
Publications - 103
Citations - 4569
Nicola Gebbia is an academic researcher from University of Palermo. The author has contributed to research in topics: Cancer & Chemotherapy. The author has an hindex of 31, co-authored 103 publications receiving 4333 citations. Previous affiliations of Nicola Gebbia include University of L'Aquila.
Papers
More filters
Journal ArticleDOI
STAT proteins: from normal control of cellular events to tumorigenesis.
Valentina Calò,Manuela Migliavacca,Viviana Bazan,Marcella Macaluso,Marcella Macaluso,Maria Buscemi,Nicola Gebbia,Antonio Russo +7 more
TL;DR: Signal transducers and activators of transcription (STAT) proteins comprise a family of transcription factors latent in the cytoplasm that participate in normal cellular events, such as differentiation, proliferation, cell survival, apoptosis, and angiogenesis following cytokine, growth factor, and hormone signaling.
Journal ArticleDOI
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli,David Vermijlen,Fabio Fulfaro,Nadia Caccamo,Serena Meraviglia,Giuseppe Cicero,Andrew Roberts,Simona Buccheri,M. D'Asaro,Nicola Gebbia,Alfredo Salerno,Matthias Eberl,Adrian Hayday +12 more
TL;DR: Zoledronate + IL-2 represents a novel, safe, and feasible approach to induce immunologic and clinical responses in patients with metastatic carcinomas, potentially providing a substantially increased window for specific approaches to be administered.
Journal ArticleDOI
The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant Treatment
TL;DR: Analysis of TP53 mutations from a large cohort of CRC patients has identified tumor site, type of mutation, and adjuvant treatment as important factors in determining the prognostic significance of this genetic alteration.
Journal ArticleDOI
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
Francesco Dieli,Nicola Gebbia,Fabrizio Poccia,Nadia Caccamo,Carla Montesano,Fabio Fulfaro,Carlo Arcara,Maria Rosaria Valerio,Serena Meraviglia,Caterina Di Sano,Guido Sireci,Alfredo Salerno +11 more
TL;DR: Bisphosphonates are analogues of endogenous pyrophosphate in which a carbon atom replaces the central atom of oxygen and this carbon substitution makes these compounds resistant to hydrolysis and allows 2 additional chains of variable structure.
Journal ArticleDOI
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Sandra Cascio,Aleco D'Andrea,Rita Ferla,Eva Surmacz,Eliana Gulotta,Valeria Amodeo,V. Bazan,Nicola Gebbia,Antonio Russo +8 more
TL;DR: It is demonstrated, for the first time, that the VEGF expression in breast cancer cells is mediated by HIF‐1 and STAT3 in a miR‐20b‐dependent manner.